Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Short-term Investments (2020 - 2024)

Historic Short-term Investments for Cytek Biosciences (CTKB) over the last 4 years, with Q4 2024 value amounting to $29000.0.

  • Cytek Biosciences' Short-term Investments fell 9123.87% to $29000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $29000.0, marking a year-over-year decrease of 9123.87%. This contributed to the annual value of $29000.0 for FY2024, which is 9123.87% down from last year.
  • As of Q4 2024, Cytek Biosciences' Short-term Investments stood at $29000.0, which was down 9123.87% from $31000.0 recorded in Q3 2024.
  • Over the past 5 years, Cytek Biosciences' Short-term Investments peaked at $2.9 million during Q1 2023, and registered a low of $29000.0 during Q4 2024.
  • In the last 4 years, Cytek Biosciences' Short-term Investments had a median value of $365500.0 in 2023 and averaged $940750.0.
  • Within the past 5 years, the most significant YoY rise in Cytek Biosciences' Short-term Investments was 8629.2% (2024), while the steepest drop was 9123.87% (2024).
  • Quarter analysis of 4 years shows Cytek Biosciences' Short-term Investments stood at $888000.0 in 2020, then soared by 226.46% to $2.9 million in 2022, then tumbled by 88.58% to $331000.0 in 2023, then plummeted by 91.24% to $29000.0 in 2024.
  • Its Short-term Investments stands at $29000.0 for Q4 2024, versus $31000.0 for Q3 2024 and $30000.0 for Q2 2024.